SI
SI
discoversearch

Biotech / Medical
ONCOCYTE :Liquid Biopsy
An SI Board Since January 2016
Posts SubjectMarks Bans Symbol
29 6 0 OCX
Emcee:  Savant Type:  Moderated




About OncoCyte Corporation

OncoCyte is primarily focused on the development and commercialization of novel, non-invasive liquid biopsy diagnostic tests for the early detection of cancer to improve health outcomes through early diagnoses, to reduce the cost of care through the avoidance of more costly diagnostic procedures, including invasive biopsy and cystoscopic procedures, and to improve the quality of life for cancer patients.

While current biopsy tests use invasive surgical procedures to provide tissue samples in order to determine if a tumor is benign or malignant, OncoCyte is developing a next generation of diagnostic tests that will be liquid biopsies using blood or urine samples. OncoCyte’s initial liquid biopsy tests under development are intended to be confirmatory diagnostics for detecting lung, bladder and breast cancer. OncoCyte’s diagnostic tests are being developed using proprietary sets of genetic and protein markers broadly expressed in numerous types of cancer.

For more information about OncoCyte, please visit www.OncoCyte.com.

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
29Bullish crossover in MACD and Stochastics. [graphic]hollyhunter-September 12
28 OCX..good news progress OncoCyte Receives CLIA Certification for its Cancer DiaSavant-September 7
27FYI: Liquid biopsy startup RareCyte announces $30M round and new CEO to fuel raGlenn Petersen1August 30
26OncoCyte Confirms Launch Plans for Lung Cancer Diagnostic Test; Reports ProgressSavant-August 15
25OncoCyte Latest Lung Cancer Diagnostic Test Data Accepted for Slide PresentationSavant-August 8
24OncoCyte Corp. (OCX) filed a Form 8K - Unregistered Sales of Equity - with the USavant-July 31
23 OncoCyte Corporation Set to Join Russell 3000(R) Index ALAMEDA, Calif., June 1Savant-June 12
22 Presentation PDF globenewswire.com >>> investors.oncocyte.comSavant-May 27
21OncoCyte Presents Positive Lung Cancer Blood Test Data at American Thoracic SociSavant-May 23
20lots of news, pps jump, stock halted, reopened..up 23.5%Savant-May 23
19OncoCyte Reports Successful Results of Lung Cancer Diagnostic Test Study; TargetSavant-March 6
18OncoCyte Corporation to Present at Cowen and Company 37th Annual Health Care ConSavant-March 1
17Looks like good entry point here. [graphic]hollyhunter-February 27
16OncoCyte Corporation Reports Fourth Quarter and Full Year 2016 Financial ResultsSavant-February 27
15OncoCyte Wins Buzz of BIO for the 2017 BIO CEO & Investor Conference ALAMESavant-January 27
14Bullish crossover in MACD and Stochastic oscillator. [graphic]hollyhunter-12/15/2016
13SAN DIEGO, Dec. 7, 2016 /PRNewswire/ -- Organovo Holdings, Inc. (NASDAQ:ONVO) (&Savant-12/7/2016
12DEC 9th presentation... OncoCyte Corporation (NYSE MKT:OCX), a developer of novSavant-11/30/2016
11OncoCyte and The Wistar Institute Present Lung Cancer Diagnostic Data at the CHESavant-10/17/2016
10OncoCyte Corporation to Present at the BIO Investor Forum ALAMEDA, Calif., Oct.Savant-10/14/2016
9OncoCyte to Present Initial Data on its Breast Cancer Diagnostic Test at the PreSavant-9/8/2016
8OncoCyte Corporation to Present at the Annual Gateway Conference ALAMEDA, CalifSavant-9/7/2016
7OncoCyte Corporation Announces the Closing of Two Private Placement TransactionsSavant-8/29/2016
6OncoCyte Commences Analytical Verification Study for Lung Cancer Diagnostic TestSavant-8/10/2016
5OncoCyte and The Wistar Institute Announce Presentation of Lung Data at CHEST 20Savant-7/27/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.